BN Business News
Add your company to Business Communicator →

BUSINESS NEWS

Search Business News

Find articles by title or summary.

4/15/2021

Submission for OMB Review: Novation and Change-of-Name Agreements

The Regulatory Secretariat Division has submitted a request to the Office of Management and Budget (OMB) to review and approve a revision and extension of information collection requirements related to improper business practices and personal conflicts of interest, following the Paperwork Reduction Act.

4/15/2021

Public Comment Invited on Revised Delivery Schedules for Federal Government Acquisitions

The Department of Defense (DoD), General Services Administration (GSA), and National Aeronautics and Space Administration (NASA) are seeking public input on a proposed revision and renewal of their delivery schedules, which are governed by the Paperwork Reduction Act of 1995 and Office of Management and Budget (OMB) regulations. The proposed changes aim to enhance the quality and utility of the information collected, while minimizing the burden on respondents.

4/15/2021

SIGPR Proposes Exemption from Privacy Act for New Systems of Records

The Department of the Treasury is proposing an exemption for new systems of records maintained by the Special Inspector General for Pandemic Recovery from certain provisions of the Privacy Act of 1974, as amended, in accordance with the requirements of the Privacy Act of 1974, as amended.

4/15/2021

Comment Request for Form 3491: Proposed Collection

The Internal Revenue Service (IRS) is seeking public comments on Form 3491, a consumer cooperative exemption application, as part of its efforts to reduce paperwork and respondent burden, in accordance with the Paperwork Reduction Act of 1995.

4/15/2021

US Designates Russian Entities and Individuals for Proliferation of Weapons of Mass Destruction

The US State Department, in consultation with the Treasury Secretary and Attorney General, has designated several Russian entities and individuals for their involvement in activities that contribute to the proliferation of weapons of mass destruction, as mandated by the Executive Order on Blocking Property of Weapons of Mass Destruction Proliferators and Their Supporters.

4/15/2021

FEMA Declares Major Disaster for Washington State

The Federal Emergency Management Agency (FEMA) has issued a public assistance declaration for the state of Washington following a severe winter storm that caused widespread damage from December 29, 2020, to January 16, 2021, resulting in landslides, mudslides, and other hazards.

4/14/2021

FCC Announces Compliance Required for Wireless E911 Location Accuracy Requirements

The Federal Communications Commission (FCC) has announced that compliance with its Wireless E911 Location Accuracy Requirements is now mandatory, following approval from the Office of Management and Budget (OMB). The rules, which were adopted in 2020, require the FCC to publish a document in the Federal Register announcing a compliance date for the rule sections.

4/14/2021

Submission for OMB Review: Small Business Size Rerepresentation

The Regulatory Secretariat Division has submitted a request to the Office of Management and Budget (OMB) to review and approve a revision and renewal of a previously approved information collection requirement regarding small business size rerepresentation, as mandated by the Paperwork Reduction Act.

4/14/2021

Submission for OMB Review; Combating Trafficking in Persons

The Regulatory Secretariat Division has submitted a request to the Office of Management and Budget (OMB) for review and approval of a revision and renewal of a previously approved information collection requirement aimed at combating human trafficking.

4/14/2021

FDA Issues Final Debarment Order Against Mark Reinhard

The Food and Drug Administration (FDA) has permanently barred Mark Reinhard from providing services related to approved or pending drug products due to his felony conviction under the Federal Food, Drug, and Cosmetic Act (FD&C Act)

4/14/2021

FDA Submits Collection of Information for OMB Review

The Food and Drug Administration is requesting public comment on a proposed collection of information to be submitted to the Office of Management and Budget for review and clearance under the Paperwork Reduction Act of 1995.

4/14/2021

EPA Lodges Proposed Consent Judgments for Environmental Cleanup

The US Environmental Protection Agency (EPA) has lodged proposed consent judgments under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) for environmental cleanup at a specific site, as part of a settlement agreement with the responsible parties.

4/14/2021

FDIC Corrects Error in System of Records Notice

The Federal Deposit Insurance Corporation (FDIC) has issued a correction to its July 22, 2019, System of Records Notice (SORN) regarding the 'Financial Institution Investigative and Enforcement Records, FDIC-30-64-0002' system, following the discovery of an error in the original notice.

4/13/2021

FSIS Announces Renewal of Voluntary Recalls Information Collection

The Food Safety and Inspection Service is renewing its approved information collection for voluntary recalls of meat, poultry, and egg products, with no changes to the existing burden estimates, as required by the Paperwork Reduction Act of 1995 and OMB regulations.

4/13/2021

US Commission Schedules Expedited Reviews of Steel Grating from China

The US Commission is scheduling expedited reviews to assess whether revoking tariffs on steel grating from China would harm US industries, and if so, for how long. The review aims to determine if removing the tariffs would lead to continued material injury within a reasonably foreseeable time frame.

4/13/2021

FDA Submits Proposed Information Collection for OMB Review and Clearance

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, as part of its formal dispute resolution process regarding scientific and technical issues related to pharmaceutical Current Good Manufacturing Practice.